Overview

Extremely Low Gestatonal Age Infants' Paracetamol Study

Status:
Recruiting

Trial end date:
2023-03-01

Target enrollment:
0

Participant gender:
All

Summary

In the present trial, early, intravenous paracetamol is compared to placebo in extremely premature or low birth weight infants in order to evaluate the effect on ductal closure.

Phase:

Phase 1/Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Outi Aikio

Treatments:

Acetaminophen
Pharmaceutical Solutions

Criteria

Inclusion Criteria:

- Premature infants born before 28+0 gestation weeks and/or birth weight less than 1000g

Exclusion Criteria:

- Severe malformation or suspected chromosomal defect or other very severe
life-threatening disease (e.g. very severe birth asphyxia or persistent pulmonary
hypertension, etc.)